Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Topaly
Sandoz Rituximab for Treatment of Diffuse Large B-Cell Lymphoma: Interim Safety Results of the Non-Interventional, Observational, Multicenter, Open-Label Reflect Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
A Multicentre Study of Primary Breast Diffuse Large B-Cell Lymphoma in the Rituximab Era
British Journal of Haematology
Hematology
The Rituximab Maintenance Therapy Improves Prognosis of Transformed Diffuse Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Diffuse Large B-Cell Lymphoma
Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi
Haematologica
Hematology
Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply
The Lancet Oncology
Oncology
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
